Study of the Value of Maternal-fetal Transfers and Their Complexity of Their Implementation
TRANSFERT
1 other identifier
observational
500
1 country
8
Brief Summary
It is an observational, descriptive, prospective, multicenter study of 8 maternity units in Lorraine and Champagne-Ardenne, aimed at comparing the percentage of "avoidable" maternal-fetal transfers (MFTs), defined as transfers in which the delivery finally meets the acceptance criteria of the sending maternity unit, according to the obstetrical indications for these MFTs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Shorter than P25 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 19, 2024
CompletedFirst Posted
Study publicly available on registry
June 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedJune 28, 2024
June 1, 2024
1 year
June 19, 2024
June 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The percentage of "avoidable" maternal-foetal transfer (MFT)
The main evaluation criterion is "avoidable" maternal-foetal transfer (MFT), i.e. resulting in a delivery that met the acceptance criteria of the original maternity hospital
after delivery, up to 6 weeks after the maternal-foetal transfer
Secondary Outcomes (2)
Obstetrical indication for maternal-foetal transfer (MFT)
Up to 48 hours after the maternal-foetal transfer
Organizational arrangements for maternal-foetal transfer
Up to 6 months after inclusion of a maternity unit in the study
Interventions
Prospective and consecutive inclusion of all maternal-fetal transfers during the study period. The teams at the sending and receiving maternity units will complete study-related questionnaires to describe the conditions of the transfer and the outcome of the pregnancy. The study in no way alters the way parturients are cared for.
Eligibility Criteria
Maternal-fetal transfers (MFTs) for threatened premature delivery
You may qualify if:
- Pregnant woman cared for in a participating maternity unit
- Over 18 years of age
- Requested for maternal-fetal transfer (finally performed, or not)
You may not qualify if:
- missing data on transfer outcome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Hopital Maillot
Briey, France
Maternité CH Léon Bourgeois
Châlons-en-Champagne, France
CHR Metz Thionville Hopital Femme Mère Enfant
Metz, 57085, France
Maternité - Hôpital Maurice Camuset
Romilly-sur-Seine, France
Clinique Saint Nabor
Saint-Avold, France
Matérnité Saint Dizier
Saint-Dizier, France
CHR Metz-Thionville Hopital Bel Air
Thionville, France
Hopital Saint Nicolas
Verdun, France
Study Officials
- PRINCIPAL INVESTIGATOR
Laetitia HONORE-ROUGE, MD
CHR Metz Thionville Hopital Femme Mère Enfant
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 19, 2024
First Posted
June 28, 2024
Study Start
April 1, 2024
Primary Completion
April 1, 2025
Study Completion
April 1, 2025
Last Updated
June 28, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share